A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacodynamics and the Effect of Food on the Pharmacokinetics of RO 6870868
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2016
At a glance
- Drugs RG 7863 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Roche
- 25 Mar 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 18 Feb 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.
- 03 Feb 2014 Planned End Date changed from 1 Jan 2014 to 1 Mar 2014 according to ClinicalTrials.gov record.